MEI Pharma announced its first LTC purchase, sparking a rally for one of the oldest and well-established crypto coins.

San Diego-based MEI Pharma (NASDAQ:MEIP) has acquired 929,548 Litecoin (CRYPTO: LTC) tokens, becoming the first U.S.-listed ...

Cold Wallet’s progress is accelerating, securing $5.9 million in its presale while holding a sharp 4,900% return potential ...

Follow Cold Wallet’s $5.9M presale growth backed by real users and cashback utility, while the Litecoin (LTC) price surge ...

EDT MEI Pharma (MEIP) files to sell 25.3M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, ...

Analysts told Decrypt though ETF approval rumors are adding to optimism, it’s MEI Pharma’s buy-in last month that is really ...

Infinity Pharmaceuticals has scuttled a plan to combine with MEI Pharma, whose shareholders rebuffed the merger over the weekend, the company announced Monday morning. The announcement comes days ...

MEI Pharma's portfolio of drug candidates contains four clinical-stage assets, including zandelisib, currently in an ongoing Phase 2 clinical trial which may support an accelerated approval ...

MEI Pharma has a 52-week trading range of $1.87 to $13.98. Keep in mind that Monday was the day that the 52-week low was hit, and shares had been at $6.30 on Friday’s closing bell.

MEI Pharma had cash and cash equivalents of $36.2 million as of March 31, 2018. It was anticipating at first that its cash would be enough until the 1st half of its calendar 2019.